Double maintains 6 strategies that include GH - Guardant Health, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBTL | 0.08% | $386.59M | 0.07% |
| FTXG | -0.10% | $22.31M | 0.6% |
| SCHR | -0.26% | $10.87B | 0.03% |
| CARY | -0.27% | $347.36M | 0.8% |
| TIPX | 0.31% | $1.74B | 0.15% |
| PSQA | 0.35% | $36.50M | 0.2% |
| TDTT | 0.42% | $2.63B | 0.18% |
| IBTM | 0.45% | $317.86M | 0.07% |
| SPTI | 0.45% | $8.68B | 0.03% |
| CGSM | -0.54% | $725.21M | 0.25% |
| DFNM | 0.58% | $1.59B | 0.17% |
| SHYD | -0.64% | $332.11M | 0.35% |
| GOVT | 0.87% | $27.40B | 0.05% |
| IBTK | -0.89% | $449.08M | 0.07% |
| OWNS | 0.89% | $128.82M | 0.3% |
| IBMN | 0.90% | $445.33M | 0.18% |
| BWX | 0.98% | $1.53B | 0.35% |
| VGIT | -1.17% | $31.83B | 0.04% |
| TOTL | 1.25% | $3.81B | 0.55% |
| SMMU | -1.29% | $898.04M | 0.35% |
Yahoo
PALO ALTO, Calif., July 15, 2025--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in
Finnhub
Guardant Health, Inc. announced that patient enrollment has begun in the National Cancer Institute ?s Vanguard Study to evaluate emerging multi-cancer detection technology. Guardant?s Shield? MCD...
Yahoo
PALO ALTO, Calif., July 14, 2025--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2025 after market close on Wednesday, July 30, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Yahoo
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Yahoo
New integration brings Guardant Health's complete oncology testing portfolio into the VieCure Halo Intelligence platform, streamlining access to precision diagnostics at the point of care DENVER, CO / ACCESS Newswire / July 10, 2025 / VieCure Inc., ...
Yahoo
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 60.05% | $1.10B | 0.75% |
| GNOM | 52.59% | $45.27M | 0.5% |
| IWO | 52.33% | $11.96B | 0.24% |
| RDTE | 51.34% | $140.25M | 0.97% |
| KOMP | 51.00% | $2.35B | 0.2% |
| VBK | 50.89% | $19.43B | 0.07% |
| XSW | 50.28% | $504.48M | 0.35% |
| FNY | 50.19% | $391.81M | 0.7% |
| VXF | 50.17% | $22.82B | 0.05% |
| CWB | 50.04% | $3.95B | 0.4% |
| ISCG | 49.87% | $696.78M | 0.06% |
| PTH | 49.76% | $97.64M | 0.6% |
| IWC | 49.74% | $846.53M | 0.6% |
| ARKK | 49.72% | $7.18B | 0.75% |
| KJAN | 49.38% | $283.13M | 0.79% |
| SMLF | 49.29% | $1.90B | 0.15% |
| VTWO | 49.23% | $12.69B | 0.07% |
| ICVT | 49.20% | $2.71B | 0.2% |
| PFUT | 49.14% | $363.75M | 0.65% |
| WCLD | 49.03% | $367.83M | 0.45% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -42.43% | $310.24M | 1.43% |
| VIXY | -39.22% | $200.94M | 0.85% |
| VIXM | -35.62% | $22.99M | 0.85% |
| TAIL | -33.14% | $94.90M | 0.59% |
| IVOL | -20.43% | $341.06M | 1.02% |
| FXY | -17.01% | $798.58M | 0.4% |
| XONE | -14.07% | $629.16M | 0.03% |
| BUXX | -12.74% | $312.54M | 0.25% |
| SHYM | -12.29% | $355.87M | 0.35% |
| TPMN | -10.69% | $30.86M | 0.65% |
| ULST | -10.66% | $592.71M | 0.2% |
| BILS | -10.66% | $3.80B | 0.1356% |
| SPTS | -10.51% | $5.78B | 0.03% |
| STOT | -9.78% | $254.22M | 0.45% |
| GSST | -9.63% | $925.21M | 0.16% |
| IBTG | -9.09% | $1.93B | 0.07% |
| TBLL | -9.08% | $2.12B | 0.08% |
| CANE | -9.06% | $11.17M | 0.29% |
| CLIP | -8.78% | $1.51B | 0.07% |
| LDUR | -8.75% | $907.64M | 0.5% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HAIN | 0.01% | $145.31M | -77.42% | 0.00% |
| MSIF | 0.02% | $772.77M | +36.75% | 7.52% |
| PGR | -0.02% | $145.01B | +13.94% | 1.99% |
| LNT | -0.04% | $16.08B | +16.90% | 3.16% |
| EDU | 0.08% | $8.34B | -30.67% | 0.00% |
| ERIE | 0.12% | $16.15B | -7.40% | 1.55% |
| UL | -0.12% | $149.60B | +7.04% | 3.21% |
| GO | 0.15% | $1.34B | -34.12% | 0.00% |
| NOC | -0.16% | $75.00B | +20.65% | 1.63% |
| AZO | 0.26% | $63.11B | +28.25% | 0.00% |
| KVUE | -0.32% | $41.89B | +20.49% | 3.77% |
| AIFU | -0.34% | $17.40M | +87.81% | 0.00% |
| GSK | -0.36% | $77.41B | -0.98% | 4.17% |
| LTM | 0.37% | $12.57B | -95.57% | 2.41% |
| LMT | 0.39% | $110.96B | +2.09% | 2.77% |
| AXGN | -0.39% | $547.44M | +38.80% | 0.00% |
| QNTM | 0.41% | $56.99M | +124.42% | 0.00% |
| PRPO | 0.41% | $22.45M | +220.44% | 0.00% |
| BTI | -0.47% | $112.32B | +59.44% | 5.94% |
| POR | -0.48% | $4.51B | -8.75% | 4.92% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TWST | 49.90% | $2.26B | -32.68% | 0.00% |
| TEM | 47.94% | $10.01B | +57.98% | 0.00% |
| VCYT | 47.79% | $2.09B | +17.97% | 0.00% |
| NTRA | 46.87% | $21.60B | +40.40% | 0.00% |
| ALTG | 46.54% | $258.23M | -20.69% | 2.93% |
| CYRX | 45.66% | $376.03M | +0.94% | 0.00% |
| SDGR | 45.08% | $1.55B | -6.83% | 0.00% |
| HOOD | 44.76% | $88.21B | +317.54% | 0.00% |
| RGEN | 44.57% | $6.82B | -1.04% | 0.00% |
| EPAM | 44.55% | $9.52B | -15.83% | 0.00% |
| ACA | 44.52% | $4.36B | +1.62% | 0.22% |
| RAMP | 44.16% | $2.15B | -0.28% | 0.00% |
| BROS | 44.14% | $8.05B | +49.94% | 0.00% |
| OC | 44.12% | $12.27B | -17.16% | 1.78% |
| ALNT | 43.74% | $662.09M | +43.73% | 0.31% |
| QTWO | 43.71% | $5.63B | +33.06% | 0.00% |
| KFY | 43.47% | $3.85B | +8.53% | 2.29% |
| LFMD | 43.36% | $514.47M | +69.21% | 0.00% |
| RDW | 42.97% | $2.53B | +119.16% | 0.00% |
| CEVA | 42.91% | $539.31M | +8.67% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -23.71% | $24.71B | +36.77% | 1.07% |
| MO | -18.41% | $97.92B | +21.81% | 7.02% |
| KMB | -17.78% | $42.29B | -9.61% | 3.90% |
| AWK | -17.46% | $27.95B | +5.15% | 2.18% |
| ED | -16.93% | $36.39B | +11.91% | 3.34% |
| CME | -15.08% | $99.84B | +44.13% | 1.75% |
| VZ | -14.44% | $175.31B | +1.94% | 6.53% |
| K | -12.81% | $27.64B | +41.46% | 2.87% |
| CL | -12.55% | $72.01B | -8.64% | 2.28% |
| TEF | -11.38% | $29.40B | +19.77% | 6.32% |
| CAG | -11.32% | $9.25B | -32.24% | 7.20% |
| GIS | -11.30% | $27.65B | -18.92% | 4.74% |
| VSA | -11.06% | $12.16M | +21.20% | 0.00% |
| KO | -11.01% | $299.02B | +9.56% | 2.87% |
| PPC | -10.94% | $10.68B | +32.81% | 0.00% |
| SO | -10.82% | $101.86B | +15.78% | 3.13% |
| MDLZ | -10.40% | $87.58B | +5.11% | 2.79% |
| PEP | -10.39% | $185.88B | -17.26% | 4.07% |
| CPB | -10.11% | $9.16B | -32.65% | 5.03% |
| MKTX | -9.44% | $8.15B | -1.09% | 1.39% |
Current Value
$48.391 Year Return
Current Value
$48.391 Year Return
